These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 21450068)
1. Management of cardiac fibrosis in diabetic rats; the role of peroxisome proliferator activated receptor gamma (PPAR-gamma) and calcium channel blockers (CCBs). Mohamad HE; Askar ME; Hafez MM Diabetol Metab Syndr; 2011 Mar; 3(1):4. PubMed ID: 21450068 [TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity. El-Bassossy HM; Abo-Warda SM; Fahmy A Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):643-9. PubMed ID: 22594672 [TBL] [Abstract][Full Text] [Related]
3. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance. Gaikwad AB; Viswanad B; Ramarao P Pharmacol Res; 2007 May; 55(5):400-7. PubMed ID: 17369046 [TBL] [Abstract][Full Text] [Related]
4. Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling. Shen N; Li X; Zhou T; Bilal MU; Du N; Hu Y; Qin W; Xie Y; Wang H; Wu J; Ju J; Fang Z; Wang L; Zhang Y J Ethnopharmacol; 2014 Nov; 157():161-70. PubMed ID: 25267579 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management. Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395 [TBL] [Abstract][Full Text] [Related]
6. Modulation of metabolic and cardiac dysfunctions by insulin sensitizers and angiotensin receptor blocker in rat model of type 2 diabetes mellitus. Hussein Ael-A; Omar NM; Sakr H; Elsamanoudy AZ; Shaheen D Can J Physiol Pharmacol; 2011 Mar; 89(3):216-26. PubMed ID: 21423295 [TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin Gallate Protects Diabetes Mellitus Rats Complicated with Cardiomyopathy through TGF-β1/JNK Signaling Pathway. Gui L; Wang F; Hu X; Liu X; Yang H; Cai Z; Qi M; Dai C Curr Pharm Des; 2022; 28(33):2758-2770. PubMed ID: 36173051 [TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor. Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320 [TBL] [Abstract][Full Text] [Related]
10. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts. Hao GH; Niu XL; Gao DF; Wei J; Wang NP Br J Pharmacol; 2008 Apr; 153(7):1409-19. PubMed ID: 18278065 [TBL] [Abstract][Full Text] [Related]
11. Targeting apoptosis in the heart of streptozotocin-induced diabetic rats. Baraka A; AbdelGawad H J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):175-81. PubMed ID: 20133494 [TBL] [Abstract][Full Text] [Related]
12. Swimming exercise improves gene expression of PPAR-γ and downregulates the overexpression of TLR4, MyD88, IL-6, and TNF-α after high-fat diet in rat skeletal muscle cells. Shirvani H; Mirnejad R; Soleimani M; Arabzadeh E Gene; 2021 Apr; 775():145441. PubMed ID: 33482280 [TBL] [Abstract][Full Text] [Related]
13. Cardiac peroxisome-proliferator-activated receptor expression in hypertension co-existing with diabetes. Lee TI; Kao YH; Chen YC; Pan NH; Lin YK; Chen YJ Clin Sci (Lond); 2011 Oct; 121(7):305-12. PubMed ID: 21501116 [TBL] [Abstract][Full Text] [Related]
14. Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance. El Mesallamy HO; El-Demerdash E; Hammad LN; El Magdoub HM Diabetol Metab Syndr; 2010 Jun; 2():46. PubMed ID: 20591133 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of benign biliary stricture inhibition by rosiglitazone-activated peroxisome proliferator-activated receptor gamma. Jiamei L; Liang Y; Jianhua S Rev Assoc Med Bras (1992); 2022; 68(10):1400-1404. PubMed ID: 36417643 [TBL] [Abstract][Full Text] [Related]
17. [An experimental study on the reverse mechanism of PPAR-gamma agonist rosiglitazone in rats with non-alcoholic steatohepatitis]. Zhao CY; Wang YD; Zhou JY; Jia B; Cui JF Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):450-5. PubMed ID: 17594812 [TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway. Gbr AA; Abdel Baky NA; Mohamed EA; Zaky HS Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):349-360. PubMed ID: 32984914 [TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone attenuates myocardial remodeling in spontaneously hypertensive rats. Ti Y; Hao MX; Li CB; Wang ZH; Hou XY; Zhao XQ; Liu JN; Zhang W; Zhang Y; Bu PL Hypertens Res; 2011 Mar; 34(3):354-60. PubMed ID: 21248758 [TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma. Wu M; Melichian DS; Chang E; Warner-Blankenship M; Ghosh AK; Varga J Am J Pathol; 2009 Feb; 174(2):519-33. PubMed ID: 19147827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]